Measurement of plasma vitamin K1 (phylloquinone) and K2 (menaquinones-4 and -7) using HPLC-tandem mass spectrometry. 2016

Ineke J Riphagen, and Jan C van der Molen, and Martijn van Faassen, and Gerjan Navis, and Martin H de Borst, and Frits A J Muskiet, and Wilhelmina H A de Jong, and Stephan J L Bakker, and Ido P Kema

BACKGROUND Given the growing interest in the health benefits of vitamin K, there is great need for development of new high-throughput methods for quantitative determination of vitamin K in plasma. We describe a simple and rapid method for measurement of plasma vitamin K1 (phylloquinone [PK]) and K2 (menaquinones [MK]-4 and -7). Furthermore, we investigated the association of fasting plasma vitamin K with functional vitamin K insufficiency in renal transplant recipients (RTR). METHODS We used HPLC-tandem mass spectrometry with atmospheric pressure chemical ionization for measurement of plasma PK, MK-4, and MK-7. Solid-phase extraction was used for sample clean-up. Mass spectrometric detection was performed in multiple reaction monitoring mode. Functional vitamin K insufficiency was defined as plasma desphospho-uncarboxylated matrix Gla protein (dp-ucMGP) >500 pmol/L. RESULTS Lower limits of quantitation were 0.14 nmol/L for PK and MK-4 and 4.40 nmol/L for MK-7. Linearity up to 15 nmol/L was excellent. Mean recoveries were >92%. Fasting plasma PK concentration was associated with recent PK intake (ρ=0.41, p=0.002) and with plasma MK-4 (ρ=0.49, p<0.001). Plasma PK (ρ=0.38, p=0.003) and MK-4 (ρ=0.46, p<0.001) were strongly correlated with plasma triglyceride concentrations. Furthermore, we found that MK-4-triglyceride ratio, but not PK-triglyceride ratio, was significantly associated with functional vitamin K insufficiency (OR 0.22 [0.07-0.70], p=0.01) in RTR. CONCLUSIONS The developed rapid and easy-to-use LC-MS/MS method for quantitative determination of PK, MK-4, and MK-7 in human plasma may be a good alternative for the labor-intensive and time-consuming LC-MS/MS methods and enables a higher sample throughput.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010837 Vitamin K 1 A family of phylloquinones that contains a ring of 2-methyl-1,4-naphthoquinone and an isoprenoid side chain. Members of this group of vitamin K 1 have only one double bond on the proximal isoprene unit. Rich sources of vitamin K 1 include green plants, algae, and photosynthetic bacteria. Vitamin K1 has antihemorrhagic and prothrombogenic activity. Phylloquinone,Phytomenadione,Phytonadione,Aquamephyton,Konakion,Phyllohydroquinone,Vitamin K1
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem
D024482 Vitamin K 2 A group of substances similar to VITAMIN K 1 which contains a ring of 2-methyl-1,4-naphthoquinione and an isoprenoid side chain of varying number of isoprene units. In vitamin K 2, each isoprene unit contains a double bond. They are produced by bacteria including the normal intestinal flora. Menaquinone,Menaquinones,Vitamin K Quinone,Vitamin K2

Related Publications

Ineke J Riphagen, and Jan C van der Molen, and Martijn van Faassen, and Gerjan Navis, and Martin H de Borst, and Frits A J Muskiet, and Wilhelmina H A de Jong, and Stephan J L Bakker, and Ido P Kema
January 1987, Journal of chromatography,
Ineke J Riphagen, and Jan C van der Molen, and Martijn van Faassen, and Gerjan Navis, and Martin H de Borst, and Frits A J Muskiet, and Wilhelmina H A de Jong, and Stephan J L Bakker, and Ido P Kema
January 2011, Journal of nutritional science and vitaminology,
Ineke J Riphagen, and Jan C van der Molen, and Martijn van Faassen, and Gerjan Navis, and Martin H de Borst, and Frits A J Muskiet, and Wilhelmina H A de Jong, and Stephan J L Bakker, and Ido P Kema
September 1967, Helvetica chimica acta,
Ineke J Riphagen, and Jan C van der Molen, and Martijn van Faassen, and Gerjan Navis, and Martin H de Borst, and Frits A J Muskiet, and Wilhelmina H A de Jong, and Stephan J L Bakker, and Ido P Kema
January 2006, Rapid communications in mass spectrometry : RCM,
Ineke J Riphagen, and Jan C van der Molen, and Martijn van Faassen, and Gerjan Navis, and Martin H de Borst, and Frits A J Muskiet, and Wilhelmina H A de Jong, and Stephan J L Bakker, and Ido P Kema
September 2004, Clinica chimica acta; international journal of clinical chemistry,
Ineke J Riphagen, and Jan C van der Molen, and Martijn van Faassen, and Gerjan Navis, and Martin H de Borst, and Frits A J Muskiet, and Wilhelmina H A de Jong, and Stephan J L Bakker, and Ido P Kema
June 2007, Journal of nutritional science and vitaminology,
Ineke J Riphagen, and Jan C van der Molen, and Martijn van Faassen, and Gerjan Navis, and Martin H de Borst, and Frits A J Muskiet, and Wilhelmina H A de Jong, and Stephan J L Bakker, and Ido P Kema
September 2007, Clinical chemistry,
Ineke J Riphagen, and Jan C van der Molen, and Martijn van Faassen, and Gerjan Navis, and Martin H de Borst, and Frits A J Muskiet, and Wilhelmina H A de Jong, and Stephan J L Bakker, and Ido P Kema
June 2009, Clinical chemistry,
Ineke J Riphagen, and Jan C van der Molen, and Martijn van Faassen, and Gerjan Navis, and Martin H de Borst, and Frits A J Muskiet, and Wilhelmina H A de Jong, and Stephan J L Bakker, and Ido P Kema
January 2010, Methods in molecular biology (Clifton, N.J.),
Ineke J Riphagen, and Jan C van der Molen, and Martijn van Faassen, and Gerjan Navis, and Martin H de Borst, and Frits A J Muskiet, and Wilhelmina H A de Jong, and Stephan J L Bakker, and Ido P Kema
January 1988, Pediatrics,
Copied contents to your clipboard!